Mallinckrodt announces FDA approval for Lisdexamfetamine Dimesylate Capsules

Lisdexamfetamine Dimesylate Capsules are intended for the treatment of Attention-Deficit/Hyperactivity Disorder and other indications. Credit: https://www.scientificanimations.com/ commons.wikimedia.org.